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Abstract 
The growing measurement of patient-reported outcomes (PROs) and adoption of 
electronic heath records (EHRs) presents an unprecedented opportunity to improve health care 
for patients and populations. The integration of PROs into EHRs can promote patient-centered 
care and advance quality improvement initiatives, research, and population health. Despite 
these potential benefits, there are few best practices to help organizations achieve integration. 
To integrate PROs into EHRs, organizations should evaluate the advantages and disadvantages 
of various approaches within three themes: Planning, Selection, and Engagement. Planning 
considerations for integration include what strategy will be used, how the integrated system 
will be governed, ethical and legal issues, and how data from multiple EHRs can be pooled 
across organizations. Selection considerations involve identifying which patient population to 
target for PRO data collection based on the intended use of the data in the health care system, 
and then choosing specific outcomes and their measures. Engagement considerations include 
how, where, and with what frequency patients will respond to PRO measures, how to display 
PRO data in EHRs, how clinical teams will act upon PRO data, and how to train, support and 
incent clinical teams and patients to incorporate PRO data into care. There is no most effective 
model that will work in all contexts. Organizations wishing to integrate PROs and EHRs should 
assemble the multidisciplinary expertise needed to evaluate the advantages and disadvantages 
of the various approaches for their particular context. We specifically recommend that 
organizations think carefully about stakeholder participation; design their system with data 
sharing in mind; develop a framework to aid in PRO selection; create guidelines to support PRO 
interpretation and action for patients and clinicians; and ensure patients have access to their 
own PRO data.  
  Integrating PROs into EHRs 
 4 
Key Points: 
1. There are a number of approaches related to planning, selection, and stakeholder 
engagement when integrating patient-reported outcomes (PROs) into electronic health 
records (EHRs), each with advantages and disadvantages.  
2. There is no single, most effective model for PRO-EHR integration that will work in all 
contexts.  
3. Health systems should assemble the multidisciplinary expertise needed to weigh the 
advantages and disadvantages of each approach for PRO-EHR integration in their particular 
context. 
 
1. Introduction 
The growing measurement of patient-reported outcomes (PROs) and adoption of 
electronic heath records (EHRs) presents an unprecedented opportunity to improve health care 
for patients and populations. PROs are direct reports from patients about their symptoms, 
functioning, health-related quality of life, or other aspects of their health that are captured 
without clinician interpretation using standardized PRO measures (i.e., instruments, 
questionnaires, surveys) [1-3]. EHRs are longitudinal electronic records of patient encounters 
and clinical data that patients, providers, and payers can access across facilities and devices [4]. 
The integration of PROs into EHRs can promote patient-centered care and advance quality 
improvement initiatives, research, and population health [5-9].  
Despite the potential benefits of integrating PROs into EHRs, there are few best 
practices to help organizations achieve integration [10-12]. In collaboration with the 
International Society for Quality of Life Research (ISOQOL) and through a contract from the 
Patient-Centered Outcomes Research Institute (PCORI), Johns Hopkins University led a 
multidisciplinary team to create the Users͛ Guide to Integrating Patient-Reported Outcomes in 
Electronic Health Records, which is available on the PCORI website 
(http://www.pcori.org/document/users-guide-integrating-patient-reported-outcomes-
electronic-health-records). The purpose of the hƐĞƌƐ ? Guide is to provide a practical framework 
and examples for administrators, clinicians, researchers, information technology (IT) 
professionals, and others wishing to integrate PROs into their EHRs. It offers guidance on 11 key 
questions related to integration, and for each question describes advantages and disadvantages 
of different options, identifies research gaps, and lists references and resources. Importantly, 
many of the options presented in ƚŚĞhƐĞƌƐ ?'ƵŝĚĞĂƌĞŶŽƚŵƵƚƵĂůůǇĞǆĐůƵƐŝǀĞ ?ĂŶĚŝƚŝƐŽĨƚĞŶ
possible and advisable to pursue more than one approach. 
The hƐĞƌƐ ? Guide was developed between August 2015 and May 2017. In Phase 1 of the 
project, a Steering Group was assembled to help clarify goals, develop strategies, and identify 
topics to be addressed. The Steering Group, PCORI, ISOQOL, and others circulated the topic list 
for public comment. In Phase 2, Working Group members were identified and formed into 
writing teams, each responsible for creating ŽŶĞŽĨƚŚĞ ? ?hƐĞƌƐ ?'ƵŝĚĞƐĞĐƚŝŽŶƐ addressing a 
key question about PRO-EHR integration. There was an in-person meeting to discuss outlines 
for each section, and writing teams then developed drafts. The drafts were presented during a 
series of conference calls with the combined Steering and Working groups (see 
Acknowledgements). The final sections were circulated for public comment, with section 
authors encouraged to give due consideration to the feedback received and to revise as they 
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deemed appropriate. The hƐĞƌƐ ?'ƵŝĚĞǁĂƐƌĞůĞĂƐĞĚŝŶƚŝŵĞĨŽƌĂDĂǇ ? ? ? ?WKZ/-hosted 
public meeting in Arlington, VA.  
In this editorial, we present the 11 key questions addressed in the hƐĞƌƐ ? Guide in 3 
thematic groups: Planning, Selection, and Engagement. For each theme, we describe the key 
questions and their important considerations and takeaways. Finally, we offer recommended 
next steps for organizations wishing to pursue PRO integration into an EHR.  
 
2. Overview of Guidance for Integration 
 
2.1. Planning 
When planning for the integration of PROs into EHRs, it is important to consider what 
strategy will be used, how the integrated system will be governed, ethical and legal issues, and 
how data from multiple EHRs can be pooled across organizations. Each consideration is 
described below, with takeaways summarized in Table 1.  
The primary planning consideration involves determining how the PRO data will be 
integrated into the EHR. The options ƌĂŶŐĞĨƌŽŵ “ĨƵůů ?ŝŶƚĞgration, where PROs are collected 
from the patient and reported directly within the EHR, to  “ŵŝŶŝŵĂů ?ŝŶƚĞŐƌĂƚŝŽŶ ?ǁŚĞƌĞƐƚĂĨĨŽƌ
clinicians manually push collected PRO data into the EHR (e.g. paper scanning, clinical note 
entry), with many options in between. Full integration allows patients, providers, researchers 
and administrators to access and act upon PRO and clinical data side-by-side, but manipulating 
elements already incorporated into the system (e.g. questionnaire language, timing of 
administration) may require a local EHR IT team or other external vendor, potentially 
constraining the customization of PROs and necessitating the prioritization of clinical needs 
over research potential. Minimal integration is likely to cost less up-front and may allow for 
greater customization of PRO collection and research independence from the clinical care 
system, but it can lead to redundancy in data collection as researchers, clinicians, and others 
gather the same data in their preferred format, and produce data that are less structured and 
less accessible in the EHR. 
Governance involves determining who will make decisions about the selection, 
implementation, analysis, data sharing, and use of PROs in EHRs. Key questions include the 
degree of centralization of governance and stakeholder diversity. A centralized governance 
model grants decision-making power to a single entity, whereas a distributed model allows 
departments or even individuals to make local decisions. A centralized model facilitates system-
wide initiatives, and makes regulatory oversight easier, but it can inhibit local innovation and 
slow deployment of condition-specific and tailored PRO measures due to bureaucracy. A 
distributed model offers greater local and PRO measure flexibility but loses the centralized 
ƐǇƐƚĞŵ ?ƐĐŽŽƌĚŝŶĂƚŝŽŶ and oversight functions. With any model, the diversity of stakeholder 
involvement is the next important governance decision. One option is for the entity that 
currently governs the EHR to also take responsibility for decisions about PROs. A broader option 
is to include additional stakeholders such as patients and their advocates, quality improvement 
officers, researchers, IT specialists, and senior administrator champions. This latter option can 
add complexity to decision-making, but it also supports patient-centered care and recognizes 
the spectrum of perspectives involved in PRO collection, analysis, and use. 
  Integrating PROs into EHRs 
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Ethical and legal issues may arise around the collection and re-use of PRO data in EHRs. 
The intended use of the PRO data  W patient care, research, or population surveillance  W affects 
decisions around protection of patient information. Depending on state and organizational legal 
and ethical requirements, organizations might choose to provide PRO measures to patients 
with no explanation of their purpose, which is expedient but will reduce patient buy-in (and 
therefore participation) and raise ethical questions. On the other end of the spectrum is to 
follow the processes around informed consent for human subject research, which might be 
most respectful to patients but would differ from usual patient care and is likely to decrease 
participation and therefore risk limiting generalizability of the data that are collected. There are 
many options in between these extremes (e.g., a PRO-specific information sheet), so 
organizations should seek ethical and legal advice to determine the most appropriate option for 
their context.  
 Although not necessary for EHR integration, it is prudent to consider early on how data 
from different ŽƌŐĂŶŝǌĂƚŝŽŶƐ ?WZK-EHR systems might be pooled in support of population 
health, quality improvement, or research efforts. Planning for pooling involves identifying a 
data warehouse to store the shared data and a data model to outline the data to be shared. 
Data warehouses can be centralized, where all data from each local EHR are stored in one 
location, or distributed, where data are stored locally and only summary data are shared with a 
central governing body. The centralized option is technically easier and facilitates cross-group 
data analysis, but safeguards to protect patient-identifiable information are critical when data 
are shared both locally and centrally. In addition, health care organizations may have concerns 
regarding how the data might be used (e.g., for competitive advantage). The distributed option 
has less risk of breaching identifiable information, but it is technically complex and impedes 
secondary data analysis across groups. Either option entails the additional challenge of 
requiring local sites to agree to structured data formats, thus identifying a data model is also 
essential for successful pooling. Attributes of data models include the feasibility of patient-level 
analyses, de-identification capabilities, and types of clinical domains, among many others. 
There are many potential models, but some options include PCORnet v3.0, Consolidated Clinical 
Document Architecture R2 (CCDA), Shared Health Research Informatics Network (SHRINE), and 
a project-specific ad hoc model [13-16]. Each model has its advantages and disadvantages in 
terms of requirements and suitability for PRO data. 
 
2.2. Selection 
To select PROs for EHR integration, it is first important to identify which patient 
population to target for PRO data collection based on the intended use of the data in the health 
care system. The next step is to choose specific outcomes and their measures. Considerations 
for selection are described below and takeaways are summarized in Table 1. 
There are two broad approaches for selecting patients for PRO measure administration 
once the intended use of PRO data is established: tailored and population-wide. The tailored 
approach involves capturing PROs from patients with specific health conditions, or who receive 
specific treatments, or who are identified using other clinical data within the EHR (e.g., lab 
results, pharmacy data). A reasonable first step for the tailored approach is to identify or 
hypothesize a clinical, public health, or quality of life need and then select the patient 
population accordingly. The tailored approach has the advantage of producing data that is 
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potentially more pertinent to individual patient management and combining PRO data with 
other clinical data in the EHR can facilitate health screening efforts. The disadvantages of the 
tailored approach include a reduced ability to make population-level comparisons, and a 
dependence on the completeness and accuracy of documentation in the EHR (e.g., encounter 
ĐŽĚŝŶŐ ?ƉƌŽďůĞŵůŝƐƚƐ ? ?ĂƐǁĞůůĂƐƚŚĞ,Z ?ƐĨƵŶĐƚŝŽŶĂů ƚŝĞƐ ?Ğ ?Ő ? ?ĂďŝůŝƚǇƚŽůŝŶŬǁŝƚŚƉŚĂƌŵĂĐǇ
data) to accurately identify patients. Population-wide options include administering PRO 
measures to an entire patient population for which a health system or department is 
accountable, or administering to all patients in certain settings, like primary care or specialty 
clinics. The advantages of a population-wide approach are that it creates a culture for PRO 
collection among patients and clinicians and can be useful for population-level analyses and 
system-wide quality improvement efforts. The main disadvantage is a limited ability to collect 
health condition-specific information (depending on the care setting), which is information that 
typically feels most relevant to patients and actionable for clinicians. Patient response burden 
can be a challenge for either approach, particularly for patients who receive care in many 
settings or who respond to screening tools that trigger longer surveys. The EHR can be used to 
automate and coordinate processes to avoid repeated testing and the selection of PRO 
measures can include computer adaptive test (CAT) options, among other features, which can 
ensure questions are relevant to individual patients, therefore minimizing burden. 
Once a patient population is identified for PRO measurement, selecting outcomes to 
measure involves choosing among multiple possible PRO domains and weighing health 
condition-specific or more generic options. Potentially relevant domains include 1) symptoms, 
such as anxiety or pain, 2) functioning, or having the physical, psychological, and social 
functioning needed to carry out daily activities, 3) social health/support, or the ƉĂƚŝĞŶƚ ?Ɛ
perspective on their social environment, 4) general health perceptions ?ŽƌƚŚĞƉĂƚŝĞŶƚ ?s 
perception of their overall health, and 5) health-related quality of life (HRQOL), a construct that 
combines many of the above domains. Each domain has its advantages and disadvantages. 
Information on symptoms, for example, is highly actionable in a clinical context, while data on 
general health perceptions or HRQOL can be less actionable, but can also be easier to compare 
across populations and can inform patient management by offering insight into behavior and 
health status. Considered another way, PROs can be categorized as relevant for a specific 
health condition (e.g., PROs for psoriasis might include symptoms like itching, redness, or 
burning) or as more generic or applicable to both patients and healthy individuals (e.g., HRQOL, 
functioning). Condition-specific PROs tend to be highly actionable in a clinical context with 
more evidence available to support their use in practice, and the relevance of this kind of PRO is 
often readily apparent to the patient. The disadvantage of condition-specific PROs is that 
patients with multiple conditions might experience response burden. More generic PROs might 
limit response burden because they are applicable across conditions as well as better facilitate 
population-level comparisons, but they can be less actionable and their purpose might be less 
apparent to patients. It may be appropriate to choose PROs from multiple domains, using 
condition-specific and/or generic PROs in different circumstances, given these advantages and 
disadvantages.  
The final task is to identify specific PRO measures for administration to patients. There 
are many criteria for measure selection, including the availability and attributes of existing PRO 
measures, desired degree of standardization or pooling of data across settings, EHR integration, 
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stakeholder perspectives, resources required, and impact on clinical practice workflow. Existing 
PRO measures can be well-validated and reliable, for example, but costly to license. Some 
questionnaires might have been tested in multiple settings and languages, but be too complex 
or costly to implement in a particular patient population. Including patient, provider, and/or 
researcher input as stakeholders can improve patient-centeredness and potentially the use of 
PRO measures, but can also lead to contradictory perspectives. It is difficult to meet all criteria, 
but the hƐĞƌƐ ? Guide offers considerations and questions for each criterion to aid in the 
selection process. 
 
2.3. Engagement 
Patients, providers, researchers, administrators, and IT experts are stakeholders who 
will likely engage regularly in different roles with the integrated PRO-EHR system. Appropriate 
stakeholder engagement is essential to ensure PROs are integrated in EHRs in a way that meets 
the needs of these various users. Specific engagement considerations include how, where, and 
with what frequency patients will respond to PRO measures, how to display PRO data in EHRs, 
how clinical teams will act upon PRO data, and how to train, support and incent clinical teams 
and patients to incorporate PRO data into care. Each consideration for engaging stakeholders is 
described below and takeaways are summarized in Table 1. 
PROs are only as useful as the quality of the data collected, which makes the patient, by 
definition, the most important stakeholder to engage in the data collection process. 
Appropriate patient input is necessary to alleviate questionnaire burden, maximize response 
rates, and limit missing or nonsensical data. Synchronizing questionnaires across clinical areas 
can streamline the collection process and reduce the number and frequency of questionnaires 
for the patient to complete. Other ways to reduce burden include remote  W rather than in-
office  W deployment of questionnaires, and offering multiple options for completion like paper 
surveys or patient portals. The EHR system can help monitor PRO measure completion and 
prompt clinical teams to follow-up on incomplete surveys. PRO-EHR system programming can 
also prevent nonsensical data submissions or require response fields before PRO measure 
submission to avoid missing data. The technological functionalities of the PRO-EHR system, 
however, determine the feasibility of these strategies to engage patients in the collection of 
high quality data. Health systems therefore need to balance a reasonable patient burden and 
desired data quality with their technological reality to determine the how, where, and 
frequency of PRO data collection. 
After data collection, the display and accessibility of PRO data influence the engagement 
of patients, clinicians, and even administrators or researchers. The PRO-EHR system can display 
data at the individual or population-level in various ways (e.g., through the patient portal, in 
clinical notes, in distinct places in the EHR). Data can take the form of numeric scores or graphs, 
cross-sectional analyses or longitudinal trends. Access to this PRO information can empower 
patients to monitor their own conditions, prompt care planning with clinicians, and enable 
managers and researchers to study health care quality. For this access to be effective, it is 
important to aid interpretation of the PRO scores and ensure that PRO reporting fits seamlessly 
in the clinical workflow. Decisions about the display and accessibility of PRO data help 
determine the ultimate clinical utility of the data. 
  Integrating PROs into EHRs 
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The next goal is to make it as easy as possible for clinicians to act upon the PRO results. 
Providing notification of new or important information while minimizing unnecessary disruption 
to clinical workflow is a necessary balance to establish. When a patient completes a PRO 
measure, the data can be incorporated passively into the medical record without notifying 
anyone, or the EHR can offer standard or conditional active notifications and decision support. 
Standard notifications might simply indicate that new PRO data are available for review, while 
conditional notifications might trigger only if a PRO score or response is concerning. The 
modality of notification is another relevant consideration. Emails or clinical messages through 
the EHR that clinicians can review at times of their choosing are less intrusive, whereas texts or 
pages are more intrusive. Emails are the least secure option and lack systematic documentation 
of the notification, whereas messaging within the EHR is secure and documented. Texts or 
pages enable a timelier response. Another consideration is who should receive the notification: 
the clinician who ordered the PRO measure, the clinician scheduled for the next visit, the 
primary care provider (PCP), a patient ŶĂǀŝŐĂƚŽƌŽƌĂĚŵŝŶŝƐƚƌĂƚŽƌ ?ŽƌƚŚĞƉĂƚŝĞŶƚ ?ƐĐŚŽŝĐĞŽĨ
provider, among other options. dŚĞ “ŽƌĚĞƌŝŶŐ ?ĐůŝŶŝĐŝĂŶis the default receiver for most clinical 
tests, and is likely to be most interested in the PRO results. The clinician seeing the patient next 
may be best positioned to act upon the PRO data, but some systems cannot identify these 
types of providers. PCPs in contrast are usually easy to identify, but excessive notifications for 
results the PCPs did not order or visits they did not conduct can lead to little or no attention 
ďĞŝŶŐƉĂŝĚƚŽƚŚĞƐĞŶŽƚŝĨŝĐĂƚŝŽŶƐ ?ŝ ?Ğ ? ? “ĂůĞƌƚĨĂƚŝŐƵĞ ? ? ? Navigators who triage PRO data to the 
appropriate clinician could reduce clinician burden but could also slow response times. Patients 
might have thoughts about which of their providers should receive the PRO data, but that also 
might not be the case. Ultimately, too many notifications or alerts, and particularly those that 
do not feel actionable, can significantly reduce the utility of the PRO.  
Even if a PRO-EHR system has all the necessary technological functionalities, the data 
are useless unless patients and clinicians have the training, support, and incentives they need to 
engage. Patients need to appreciate the relevance of PROs to their care, have access to basic 
technical support, and be able to use PRO data for self-monitoring. The health system can use 
marketing materials or scripts for office staff to convey relevance, but patients are likely to 
need more personalized conversations with clinicians or other care team members. Patients 
can learn the technical requirements for PRO measure submission in these same contexts, and 
support phone lines or emails can help patients troubleshoot issues remotely. There are fewer 
established methods to facilitate self-monitoring among patients using PRO data, but some 
might include decision support tools or algorithms. The clinical team and other office staff in 
turn need training and support to appreciate, interpret, and act on PRO data. This training 
might occur during a departmental meeting at the launch of PRO collection in a clinical setting 
and continue with on-going support at the team or individual-level. Written guidelines, e-
learning modules, or regular small group meetings can all help, particularly with interpretation 
and action, but these forums range from least to most time-intensive. Identifying staff and 
clinical team members as stakeholders in the redesign of clinic workflow can facilitate the use 
of PROs, but this effort can be time-consuming. There needs to be a culture change in the 
health system to support PRO use among both patients and clinicians, and the precise mix of 
support must adapt to the local context. Ultimately, the more patients see the PRO data being 
used to inform their care, the more likely they are to complete the questionnaires. Finally, 
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although ŶŽƚƐƉĞĐŝĨŝĐĂůůǇĐŽǀĞƌĞĚŝŶƚŚĞhƐĞƌƐ ?'ƵŝĚĞ ?ƚŚĞĂǀĂŝů ďŝůŝƚǇŽĨƐĞƌǀŝĐĞƐ ?Ğ ?Ő ? ?ŵĞŶƚĂů
health) to address the needs identified by PROs is another important consideration affecting 
the ability of both clinicians and patients to act on PRO results. 
 
Table 1. Main Takeaways for Integration Themes   
Planning 
Key Questions Takeaways 
1. What strategy will be 
used for integrating 
PROsi in EHRsii? 
Extent of PRO-EHR integration has important implications for 
cost, PRO customization, and utility across patients, providers, 
researchers and administrators. 
 
2. How will the PRO-EHR 
system be governed? 
Governance of PROs in EHRs can be centralized or distributed, 
and may involve few or many stakeholders. Cost, complexity 
of decision-making, and local flexibility are important 
considerations. 
 
3. What are the ethical 
and legal issues? 
Intended use of PRO data drives ethical and legal 
considerations around patient consent and information-
sharing; organizations should seek advice to implement 
processes appropriate to their contexts. 
 
4. How can PRO data from 
multiple EHRs be 
pooled? 
Pooling PRO data across EHRs requires the selection of a 
warehouse for data storage and a model for sharing data; 
technical ease, comfort with identifiable data, and the specific 
kind of data to be shared influence selection. 
 
Selection 
Key Questions Takeaways 
1. Which populations and 
patients are most 
suitable for collection 
and use of PRO data, 
and how can EHRs 
support identification of 
suitable patients? 
 
The intended use of a PRO drives the patient population 
selected for data collection. A population-wide approach 
would be most appropriate if the objective is to promote a 
culture of PRO collection or to compare outcomes across 
populations. A tailored approach would be most appropriate 
if the objective is to provide clinically actionable data or 
facilitate health screening. The EHR can help identify patients 
who meet either population-wide or tailored approaches and 
manage response burden. 
 
2. Which outcomes are 
important to measure 
for a given population? 
PROs can be generic or condition-specific, and can address 
symptoms, functioning, social support/health, general health 
perceptions, and health-related quality of life; many 
advantages exist for any given outcome, but the main 
disadvantage to avoid is patient response burden.  
 
  Integrating PROs into EHRs 
 11 
3. How should candidate 
PRO measures be 
evaluated? 
A variety of criteria aid in the selection of PRO measures, 
including the availability of existing measures, existing 
measure or questionnaire attributes, desired degree of 
standardization or pooling of data across settings, EHR 
integration, stakeholder perspectives, resources required and 
impact on clinical practice workflow. 
 
Engagement 
Key Questions Takeaways 
1. How, where, and with 
what frequency will 
PROs be administered? 
Balancing a reasonable patient response burden and the 
desired quality of data collection with the technological 
functionalities of the PRO-EHR system drives the how, where 
and frequency of PRO data collection. 
 
2. How will PRO data be 
displayed and accessed 
in the EHR? 
The EHR display and accessibility of PRO data affects the 
utility of the PRO data for patients, clinicians, administrators 
and researchers. Considerations include the display format 
and location within the EHR, and availability of interpretation 
aids. 
 
3. How will PRO data be 
acted upon? 
Motivating action in response to PRO data requires 
determining a notification procedure and modality, and 
identifying the appropriate provider to receive notifications to 
ŽƉƚŝŵŝǌĞƵƚŝůŝƚǇŽĨƚŚĞWZKĚĂƚĂĂŶĚĂǀŽŝĚ “ĂůĞƌƚĨĂƚŝŐƵĞ ? ? 
 
4. How can users be 
trained and engaged? 
A health system culture that supports the use of PROs is 
necessary to help patients and clinicians understand and 
utilize the PRO data. A wide range of training formats exist to 
promote this culture change, with cost and time requirements 
as the primary considerations. 
 
Abbreviations: 
i Patient-reported outcomes 
ii Electronic health records 
 
3. Recommendations 
Many of the actions and decisions needed to initiate PRO-EHR integration fall into the 
purview of ŚĞĂůƚŚƐǇƐƚĞŵůĞĂĚĞƌƐŚŝƉĂŶĚ/dƐƉĞĐŝĂůŝƐƚƐ ?tĞƚĂŬĞĂƐƚĞƉďĞǇŽŶĚƚŚĞhƐĞƌƐ ?'ƵŝĚĞ, 
and draw upon discussions from the May 2017 public PCORI meeting, to make the following 
recommendations to these stakeholders, following the three themes employed in this paper. 
Case studies that illustrate how various health systems have integrated PROs into EHRs are also 
available in Advances in the Use of Patient Reported Outcome Measures in Electronic Health 
Records, available on the PCORI website (https://www.pcori.org/assets/2013/11/PCORI-PRO-
Workshop-EHR-Landscape-Review-111913.pdf) [10]. 
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3.1. Planning 
 In planning the implementation of PROs within an EHR, it is necessary for decision 
makers to establish goals for both local implementation and higher-level coordination.  At the 
local level, leaders should identify the stakeholders crucial to PRO-EHR integration within their 
organization and develop a marketing plan with the value proposition for each stakeholder in 
mind. The input and buy-in of these stakeholders at the early planning stages of integration can 
set the initiative on the best course for success in the implementation and resulting value of the 
effort.   
 In anticipation of a future need to pool PRO data across EHR systems, decision makers 
are encouraged to use open source data standards and create and implement PRO measures 
within them. For example, classifying PRO measures using Consolidated Clinical Document 
Architecture [CCDA] or Logical Observation Identifiers Names and Codes [LOINC]) will allow 
sharing or pooling of data outside of the organization. Metadata to document how the PRO 
data were collected and information about the practice setting should also be standardized and 
collected. If decision makers are already working with other organizations, they should 
establish rules for engagement for a central data repository and network of sites. There is a 
national need for PRO scientists to develop crosswalks across PRO measures to facilitate 
analyses. 
 
3.2. Selection 
Given resource constraints, health care organizations will face many questions about 
how to select specific PRO measures for use by patients and clinicians, and how to deploy them. 
We encourage organizations and researchers to develop a broad selection framework that 
addresses cost, burden, efficiency, quality, transparency, care, and patient outcomes. 
 
3.3. Engagement 
It is crucial to engage patients so that they are motivated to provide valid responses to 
PRO measures. Similarly, it is important to engage clinicians so that they pay attention to PRO 
scores, discuss the results with patients, and act on them when appropriate. A key step to 
achieve these goals is to develop guidelines for interpretation and action for patients and 
clinicians. 
It is the right of patients who complete PRO measures to obtain the results. To do so, 
institutions should implement policies that provide easier access to the results, including 
displaying them within patient-facing platforms. It is also advantageous to design systems to 
provide patients with greater control of when and how (e.g., email, patient portal, paper) they 
complete PRO measures, similar to other communications with providers.  
 
4. Conclusion  
We have summarized the main considerations and takeaways for PRO-EHR integration 
ĨƌŽŵƚŚĞŬĞǇƋƵĞƐƚŝŽŶƐƚŚĂƚƚŚĞhƐĞƌƐ ?'ƵŝĚĞĐŽǀĞƌƐŝŶĨĂƌŵŽƌĞĚĞƚĂŝů ?A well-designed and 
integrated PRO-EHR system can help to promote patient-centered care, population health, 
quality improvement efforts, and health services research. The UsĞƌƐ ?'ƵŝĚĞĐĂŶŚĞůƉ patients, 
providers, and managers realize this potential for their own health systems, aided and informed 
by researchers and IT professionals. A health system wishing to integrate PROs into their EHR 
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must consider patient and provider burden, effect on clinical workflow, and the technological 
functionalities of their PRO-EHR system, among many other considerations. Stakeholder 
engagement is crucial to address each of these potential challenges. There is no one-size-fits-all 
solution for integration, nor is there a way to maximize any one consideration without 
minimizing some others. A health system that is firmly committed to optimizing patient 
outcomes should devote time, resources, and expertise to plan and engage to gain the full 
benefit of integrating PROs into their EHR, and into the care of their patients. 
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